Agilent Technologies Inc
NYSE:A
Agilent Technologies Inc
Cash & Cash Equivalents
Agilent Technologies Inc
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Agilent Technologies Inc
NYSE:A
|
Cash & Cash Equivalents
$1.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash & Cash Equivalents
$8.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
31%
|
CAGR 10-Years
3%
|
|
Danaher Corp
NYSE:DHR
|
Cash & Cash Equivalents
$5.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
49%
|
CAGR 10-Years
7%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash & Cash Equivalents
$853.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash & Cash Equivalents
$69.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash & Cash Equivalents
$1.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
See Also
What is Agilent Technologies Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.7B
USD
Based on the financial report for Jan 31, 2024, Agilent Technologies Inc's Cash & Cash Equivalents amounts to 1.7B USD.
What is Agilent Technologies Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-4%
Over the last year, the Cash & Cash Equivalents growth was 40%. The average annual Cash & Cash Equivalents growth rates for Agilent Technologies Inc have been 10% over the past three years , -3% over the past five years , and -4% over the past ten years .